End-of-life care in lung cancer patients in Ontario: Aggressiveness of care in the population and a description of hospital admissions

被引:65
作者
Barbera, Lisa [1 ,3 ]
Paszat, Lawrence [2 ,3 ]
Qiu, Feng [3 ]
机构
[1] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Radiat Oncol, Toronto, ON M4N 3M5, Canada
[2] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Hlth Policy Management & Evaluat, Toronto, ON M4N 3M5, Canada
[3] Inst Clin & Evaluat Sci, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
lung cancer; end-of-life care; in-hospital death;
D O I
10.1016/j.jpainsymman.2007.04.019
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The Purpose of this study was to describe (1) the aggressiveness of care in a Population of patients who die of lung cancer and (2) differences in care between a sample of lung cancer patients who died in an acute care hospital (DH) and a sample of lung cancer patients who were admitted to hospital during the last six months of life but were discharged and died elsewhere (DO). All lung cancer deaths in 2002 were identified in the provincial registry. Cases were linked to administrative sources of health care data to describe the population as a whole and the aggressiveness of the care that they received. Primary data were collected from a province-wide sample of patients' hospital charts focusing on reasons for admission, care in hospital, advanced planning, pain, and disposition. In total, 5,855 patients who died of lung cancer in 2002 were eligible for inclusion in the cohort. Rates of in-hospital death, emergency room visits, intensive care unit admissions, and chemotherapy use near the end of life were 59.5 %, 32.2%, 5.5%, and 4.6%, respectively. The records of 491 patients were abstracted for this study. The DH and DO groups were similar with respect to age, gender, neighborhood income level, and extent of metastatic disease. The most common chief complaints were shortness of breath, pain, inability to cope at home, and altered level of consciousness. Compared to patients in the DO group, those in the DH group presented with pain more often (19 % vs. 10 %, P < 0.005) and were more likely to be admitted with progressive chest malignancy (30 % vs. 21 %, P < 0.05). Regardless of reason for admission, pain was commonly documented as a problem during admission: 73.5 % in the DH group and 62.4% in the DO group (P < 0.05). Lung cancer patients are heavy users of acute care beds and the emergency room at the end of life. Those who do or do not die in hospital are similar in many respects but our results suggest those dying in hospital have more problems with pain and burden from local chest malignancy.
引用
收藏
页码:267 / 274
页数:8
相关论文
共 22 条
[1]   Improving processes of hospital care during the last hours of life [J].
Bailey, FA ;
Burgio, KL ;
Woodby, LL ;
Williams, BR ;
Redden, DT ;
Kovac, SH ;
Durham, RM ;
Goode, PS .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (15) :1722-1727
[2]   Indicators of poor quality end-of-life cancer care in Ontario [J].
Barbera, L ;
Paszat, L ;
Chartier, C .
JOURNAL OF PALLIATIVE CARE, 2006, 22 (01) :12-17
[3]   Death in hospital for cancer patients: an indicator of quality of end-of-life care [J].
Barbera, L ;
Paszat, L ;
Chartier, C .
PALLIATIVE MEDICINE, 2005, 19 (05) :435-436
[4]   Family physician continuity of care and emergency department use in end-of-life cancer care [J].
Burge, F ;
Lawson, B ;
Johnston, G .
MEDICAL CARE, 2003, 41 (08) :992-1001
[5]  
Burge F, 2003, CAN MED ASSOC J, V168, P265
[6]  
CHAN B, 2001, EMERGENCY DEP SERVIC
[7]  
Clarke E A, 1991, IARC Sci Publ, P246
[8]   ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619
[9]   Identifying potential indicators of the quality of end-of-life cancer care from administrative data [J].
Earle, CC ;
Park, ER ;
Lai, B ;
Weeks, JC ;
Ayanian, JZ ;
Block, S .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) :1133-1138
[10]   Trends in the aggressiveness of cancer care near the end of life [J].
Earle, CC ;
Neville, BA ;
Landrum, MB ;
Ayanian, JZ ;
Block, SD ;
Weeks, JC .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) :315-321